Iratumumab
Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease . 
<triplet> Iratumumab <subj> monoclonal antibody <obj> instance of